Agilent Technologies Inc (A) Stock Price Today
Key Stats
- $37.04BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $157.20FIFTY_TWO_WEEK_HIGH
- $110.24FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $38.59BENTERPRISE_VALUE
- 0.78%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Agilent Technologies Inc (A) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Agilent Technologies Inc has traded between a low of $110.24 and a high of $157.2, highlighting its annual price range. Buy and sell Agilent Technologies Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Most Recent News
Geely's Zeekr 7GT earns 5-star Euro NCAP rating under new 2026 safety protocols.
Geely Auto Group's Zeekr 7GT has achieved a five-star safety rating under the updated 2026 Euro NCAP protocols, highlighting its strong post-crash safety and crash protection. This marks Geely's ninth model to earn the top Euro NCAP rating, reflectin...
Wedbush celebrates 18 years with Cboe, highlighting market innovation and expanding digital asset trading.
Wedbush rang the closing bell at Cboe Global Markets to mark 18 years as a Cboe member, celebrating a partnership focused on innovation and market integrity. Since joining in 2008, Wedbush has supported the evolution of financial markets through new ...
Lawsuit challenges government-led censorship of Covid vaccine injury discussions on social media.
The New Civil Liberties Alliance (NCLA) filed an appeal to revive a lawsuit against the Biden Administration and private companies for censoring social media posts by individuals injured by Covid vaccines. Plaintiffs, including vaccine-injured indivi...
